Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children

Pediatric Transplantation

Volumn 13, Issue 7, 2009, Pages 831-837

  Nishio, Nobuhiro ^a   Yagasaki, Hiroshi ^a   Takahashi, Yoshiyuki ^a   Hama, Asahito ^a   Muramatsu, Hideki ^a   Tanaka, Makito ^a   Yoshida, Nao ^a   Yoshimi, Ayami ^a   Kudo, Kazuko ^a   Ito, Masafumi ^b   Kojima, Seiji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

Allogeneic stem cell transplantation; Children; Engraftment syndrome

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; ENGRAFTMENT SYNDROME; EVENT FREE SURVIVAL; FEMALE; FEVER; HISTOINCOMPATIBILITY; HLA SYSTEM; HUMAN; INCIDENCE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; RASH; RISK FACTOR; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; INFANT; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 70349956585     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01068.x     Document Type: Article

References (30)

1. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001 : 27 : 893 898.
2. Narimatsu H, Terakura S, Matsuo K, et al. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Bone Marrow Transplant 2007 : 39 : 31 39.
3. Kishi Y, Kami M, Miyakoshi S, et al. Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation 2005 : 80 : 34 40.
4. Gorak E, Geller N, Srinivasan R, et al. Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: Incidence and effects on survival. Biol Blood Marrow Transplant 2005 : 11 : 542 550.
5. Lee CK, Gingrich RD, Hohl RJ, Ajram KA. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995 : 16 : 175 182.
6. Moreb JS, Kubilis PS, Mullins DL, Myers L, Youngblood M, Hutcheson C. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients. Bone Marrow Transplant 1997 : 19 : 101 106.
7. Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M. Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria. Bone Marrow Transplant 2000 : 31 : 393 397.
8. Akasheh M, Eastwood D, Vesole DH. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF). Bone Marrow Transplant 2003 : 31 : 113 116.
9. Edenfield WJ, Moores LK, Goodwin G, Lee N. An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose. Bone Marrow Transplant 2000 : 25 : 405 409.
10. Ravoet C, Feremans W, Husson B, et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant 1996 : 18 : 943 947.
11. Oyama Y, Cohen B, Traynor A, Brush M, Rodriguez J, Burt RK. Engraftment syndrome: A common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplant 2002 : 29 : 81 85.
12. Madero L, Vicent MG, Sevilla J, Prudencio M, Rodriguez F, Diaz MA. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002 : 30 : 355 358. (Pubitemid 35203507)
13. Capizzi SA, Kumar S, Huneke NE, et al. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2001 : 27 : 1299 1303.
14. Nurnberger W, Willers R, Burdach S, Gobel U. Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol 1997 : 74 : 221 224.
15. Cahill RA, Spitzer TR, Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 1996 : 18 : 177 184.
16. Gonzalez-Vicent M, Ramirez M, Sevilla J, et al. Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: A prospective evaluation of risk factors and outcome. Bone Marrow Transplant 2004 : 34 : 1051 1055. (Pubitemid 40028837)
17. Foncillas MA, Diaz MA, Sevilla J, et al. Engraftment syndrome emerges as the main cause of transplant-related mortality in pediatric patients receiving autologous peripheral blood progenitor cell transplantation. J Pediatr Hematol Oncol 2004 : 26 : 492 496. (Pubitemid 39045465)
18. Schmid I, Stachel D, Pagel P, Albert MH. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 2008 : 14 : 438 444.
19. Champlin R, Khouri I, Shimoni A, et al. Harnessing graft-versus- malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy. Br J Haematol 2000 : 111 : 18 29.
20. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995 : 15 : 825 828.
21. Prentice RL, Kalbfleisch JD, Peterson AV Jr., Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978 : 34 : 541 554.
22. Kawano C, Muroi K, Kuribara R, et al. Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration. Bone Marrow Transplant 2000 : 25 : 228 229.
23. Powles R, Pedrazzini A, Crofts M, et al. Mismatched family bone marrow transplantation. Semin Hematol 1984 : 21 : 182 187.
24. Sullivan KM, Deeg HJ, Sanders J, et al. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood 1986 : 67 : 1172 1175.
25. Kim DH, Sohn SK, Kim JG, Suh JS, Lee KS, Lee KB. Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation. Bone Marrow Transplant 2004 : 33 : 1025 1030.
26. Saliba RM, de Lima M, Giralt S, et al. Hyperacute GVHD: Risk factors, outcomes, and clinical implications. Blood 2007 : 109 : 2751 2758.
27. Linden E, McAfee SL, Dey BR, et al. Outcomes of patients with engraftment syndrome following nonmyeloablative hematopoietic stem cell transplant for hematologic malignancy (abstract). Blood 2005 : 106 : 1019a.
28. Colby C, McAfee S, Sackstein R, et al. Engraftment syndrome following nonmyeloablative conditioning therapy and HLA matched bone marrow transplantation for hematologic malignancy (abstract). Blood 2000 : 96 : 520a.
29. Barksdale SK, Oberlender SA, Barnhill RL. "Rush" skin biopsy specimens in a tertiary medical center: Diagnostic yield and clinical utility. J Am Acad Dermatol 1998 : 38 : 548 554.
30. Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected acute graft-vs-host disease: Results of decision analysis. Arch Dermatol 2006 : 142 : 175 182.